Janus Henderson Group PLC Mereo Biopharma Group PLC Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Janus Henderson Group PLC holds 17,688,592 shares of MREO stock, worth $29.4 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
17,688,592
Previous 22,735,121
22.2%
Holding current value
$29.4 Million
Previous $51.2 Million
6.29%
% of portfolio
0.02%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding MREO
# of Institutions
98Shares Held
98.2MCall Options Held
2.28MPut Options Held
761K-
Rubric Capital Management LP New York, NY15.3MShares$25.4 Million0.96% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA9.44MShares$15.7 Million1.35% of portfolio
-
Mangrove Partners New York, NY8.64MShares$14.3 Million3.39% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY6.71MShares$11.1 Million0.42% of portfolio
-
Alkeon Capital Management LLC New York, NY4.7MShares$7.8 Million0.02% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $207M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...